Commission on Surgical Therapies
Reports
Annual Reports
2023: Surgical Therapies Commission Annual Report
2022: Surgical Therapies Commission Annual Report
2021: Surgical Therapies Commission Annual Report
2020: Surgical Therapies Commission Annual Report
2019: Surgical Therapies Commission Annual Report
2018: Surgical Therapies Commission Annual Report
2015: Surgical Therapies Commission Annual Report
2014: Annual Report 2014 - Surgical Therapies Commission | Commission Report
2013: Annual Report | Therapeutics Commission Report
2012: Annual Report
Activity Reports
Epilepsy Surgery Mentoring in Paraguay, Paraguayan League Against Epilepsy (2023)
Guidelines
Neurostimulation in People with Drug-Resistant Epilepsy: Systematic Review and Meta-Analysis from the ILAE Surgical Therapies Commission, Epilepsia (2022)
Establishing criteria for pediatric epilepsy surgery center levels of care: Report from the ILAE Pediatric Epilepsy Surgery Task Force, Epilepsia (2020)
Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN (2012)
Pregnancy registries: Differences, similarities, and possible harmonization (2010)
Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies (2008)
Definition of Drug-Resistant Epilepsy
The Commission on Therapeutic Strategies charged a Task Force to draft a definition of Drug-Resistant Epilepsy. The resulting report was prepared in 2009 and was published in Epilepsia in 2010. (Epilepsia, 51(6):1069–1077, 2010).
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies, 2009
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community